Job creations
Amidst the pandemic, the biopharma industry continues to surge ahead. Jobs look plentiful. Check out these companies that have made recent job announcement expansions.
Biotech companies expand their footprint and capabilities in a COVID-19 world.
The COVID-19 pandemic isn’t likely to end soon. Instead, the crisis stage may continue for weeks or even months before business regains some semblance of normality. The good news is that while biotech companies have slowed their hiring initiatives, layoffs remain unlikely at this point. Instead, biotech companies are enhancing flexibility on nearly every front.
It is planned to go into operation in 2021, and is expected to create more than 200 new jobs in Lee County, North Carolina.
Are you in the United Kingdom and looking for a job in the life sciences? Or, are you planning on having a career in the life sciences? If so, then, you’ll be happy to know that there are an expected 133,000 jobs to be added to the sector over the next 10 years.
Bayer is moving closer to a $10 billion settlement over the Roundup lawsuits and the company is in the midst of restructuring.
There’s a growing demand for life sciences professionals in Massachusetts, but a new report indicates that the home-grown talent pipeline is not adequate enough to meet the growing demands in the Bay State.
It was a busy week for biotech quarterly and annual reports. Here’s a look at some of the top stories including Bristol-Myers Squibb, AbbVie, GSK, Merck and more.
All three companies have invested millions in the facilities to expand their global footprint.
The positions will be in manufacturing, assembly and packaging. The NC Department of Commerce approved the incentives this morning.
PRESS RELEASES